EARNING RECAP

TrueCar Inc

#TRUE 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 3c est. 5c $91.1M est. $95.67M -24.80% ($7.70 closing price) $8.46 $7.69 Record low; sees Q1 revenue $84-$86M est. $93.06M; sees Fy19 revenue of $371M- $378M; est. $410.24; TRUE Acquires 20% of Accu- trade
Q2 3c est. 3c $87.9M est. $87.89M +12.39% (12.79 closing) $13.64 $11.55 sees Q3 revenue of $93M-$95M est. $94.49M; sees FY18 revenue $360M-$365M est. $361.25M
#TRUE 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 5c est. 0c $83.1M est. $81.8M. -6.13% ( $11.18 closing) $11.39 $10.85 sees Q1 revenue $80M-$82M, est. $82.27M; FY18 revenue $360M-$365M, est. $362.83M
Q3 2c est. 1c $82.4M est. $87M -35.25% (*10.58 closing price*) $11.89 $10.45 Lowers FY '17 revenue to $321M-$323M from $325M-$329M, est. $328.5; guides Q4 rev. $81M-$83M est. $84.20M
Q2 1c vs. 0c $81.8 vs. $80.7M -14.25% $17.50 $16.35
Q1 1c VS 2c est $75.8m vs $73.51m +2.83% @ $17.80 $18.76 $17.69 +6.01% ah at $18.35. 2017 revenue $322M-$327M, consensus $320.38M.

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.